The Prescription Drug Marketing Act (PDMA) was enacted on April 22, 1988 to respond to problems relating to the safety, efficacy, storage and handling of pharmaceuticals. PDMA established specific requirements for the selling and distribution of prescription drugs. Included in these is a requirement that wholesale distributors of prescription drugs be state licensed according to FDA minimum standards. On December 3, 1999, FDA published the final regulation completing the implementation of the Act. This final rule includes provisions dealing with the "authorized distributor of record" and "drug pedigree" elements of PDMA. 

As a customer of DMS Pharmaceutical, you can be assured that we meet all pedigree requirements and only purchase directly from the manufacturer or the manufacturer’s exclusive distributor, thus minimizing the risk of obtaining counterfeit products.

To learn more about FDA pedigree requirements and legislation, please see: